Article
Resist the Temptation of Response-Adaptive Randomization
26 Mar 2020
Abstract excerpt
Response-adaptive randomization (RAR) has recently gained popularity in clinical trials. The intent is noble: minimize the number of participants randomized to inferior treatments and increase the amount of information about better treatments. Unfortunately, RAR causes many problems, including (1) bias from temporal trends, (2) inefficiency in treatment effect estimation, (3) volatility in sample-size...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
